Scroll To Top
Search by Speciality

APASL 2018 – The 27th Conference of the Asian Pacific Association for the Study of the Liver

The Ashok Hotel * | New delhi, INDIA
From 200 to 750 USD
Event Preview
This event
is Finished
Title: APASL 2018 - The 27th Conference of the Asian Pacific Association for the Study of the Liver
Specialty: Internal Medicine
Dates: From Mar, 14, 2018 to Mar, 18, 2018
Location: New delhi, INDIA
Type: Conference
Registration Cost: From 200 to 750 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for New Delhi, India.
General Info
Event Venue:

The Ashok Hotel *

New Delhi, INDIA Visit the Venue to read more
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Dear Colleagues,

It is a great pleasure for us to invite you to the 27th Asian Pacific Association for the Study of the Liver (APASL 2018) that will be held from March 14 to 18, 2018 in New Delhi, India.. We are delighted to welcome you to the cultural and historical metropolis of New Delhi.

The conference program will have high quality content with up-to-date information by eminent researchers and clinicians, covering all aspects of Hepatology. 

The conference will provide an avenue for cooperation and collaboration amongst various institutions, academicia, companies, associations, non-profit organizations, and other related sectors, to deliver benefits to the people in the Asian Pacific region, where liver disease continues to be a major problem area. 

This would be the perfect opportunity for all of us to share our views, values, experiences and practices regarding liver diseases, such as Viral Hepatitis, Liver Cancers, NASH, Liver Failure, Portal hypertension, Alcoholic Liver Disease, Liver Transplantation, Pediatric Liver Diseases, Liver Radiology, and other topics.

We are looking forward to welcome you to New Delhi. 

With warmest regards,

Dr. Shiv K Sarin

Honorary President

Dr. B C Sharma


Dr. Manoj K Sharma

Organizing Secretary

Registration Needs updating Register Now
General Info:

1. * Valid membership number required (Membership fees paid until December 31 2017). New membership applications and payments received after December 31 2017 will NOT entitle the discounted registration fee.

2. ** Copy of the university card or a letter from the head of department or university is required to be submitted to Conference Secretariat at Institute of Liver and Biliary Sciences, D-1 Vasant Kunj, New Delhi - 110070, India. 

3. *** Accompanying Persons\' registration fee includes entrance to the Welcome Reception, Opening Ceremony and all scheduled coffee breaks and lunches, but NOT admitted to participate all scientific sessions.


Govt. Service Tax @18% and applicable bank charges are the responsibility of the participant and must be paid in addition to the registration fees.



Registration Cost
Early Registration

Late Registration From: 2017-10-11 To: 0--
On site Registration
APASL Member
Non-APASL member

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts


• We are holding rooms in above hotels from 13th March to 18th March, 2018.

• Above rates are inclusive of Buffet Breakfast and GST. 

For booking please contact below:

Ms. Manisha 

Mobile: +91-8800899833


Accommodation Options and Cost

Hotel Name
Type of charge
Distance from Venue
The Lalit
Date range
Hyatt Regency
Date range
Taj Palace
Date range
Scientific Content Up to Date
Submission Info
Abstract submission deadline 2017-12-15
Editorial Guidelines for Abstract Submission

Abstracts must be submitted electronically via the conference website. No faxed or mailed abstracts will be accepted. There are no exceptions to the deadline as the review period ensues immediately after the submission site closes.

Official Language

All presentations at APASL Annual Meeting 2018 will be in English. 

Submission Categories

Authors must select a submissions category when submitting their abstract. Please find the below Full List Of Abstract Submission Categories: 

Acute Liver Failure and Artificial Liver Support-Clinical

• CA-01 Acute Liver Failure and Artificial Liver Support-Clinical

Acute Liver Failure and Artificial Liver Support- Basic

• BA-01 Acute Liver Failure and Artificial Liver Support-Basic Science

Alcoholic Liver Disease-Clinical

• CAL-01 Alcoholic Liver Disease: Clinical and Therapeutic

Alcoholic Liver Disease-Basic

• BAL-01 Alcoholic Liver Disease: Experimental

Hepatitis B and D-Clinical

• CB-01 Diagnostics, Epidemiology, Prevention, Natural History

• CB-02 Therapeutics: New and Approved

Hepatitis B and D-Basic

• BB-01 Virology, Pathogenesis, and Immunology

Biliary and pancreatic Neoplasia other than Liver cancer-Clinical

• CBN-01 Diagnostics and Liver Imaging of biliary and pancreatic neoplasia 

• CBN-02 Prognosis : biliary and pancreatic neoplasia 

• CBN-03 Surgery and Loco-Regional Therapy for biliary and pancreatic neoplasia 

• CBN-04 Targetted and systemic therapies for biliary and pancreatic neoplasia

Biliary and pancreatic Neoplasia other than Liver cancer-Basic

• BBN-01 Experimental carcinogenesis of biliary and pancreatic neoplasia

Hepatitis C-Clinical

• CC-01 Diagnostics, Epidemiology, Natural History

• CC-02 Therapeutics: Preclinical and Early Clinical Development

• CC-03 Therapeutics: New Agents (not approved, phase 2-3)

• CC-04 Therapeutics: Approved Agents

Hepatitis C-Basic

• BC-01 Virology, Pathogenesis, and Immunology

Cholestatic and Autoimmune Liver Diseases-Clinical

• CCA-01 PBC/PSC and Other Cholestatic Disease: Clinical and Therapeutics

• CCA-02 Autoimmune Liver Disease: Clinical and Therapeutics

Cholestatic and Autoimmune Liver Diseases-Basic

• BCA-01 Transport, Bilirubin, Cholesterol, Lipids and Bile Salts, Cholangiocyte    Biology and Experimental Cholestasis

• BCA-02 Autoimmune Liver Disease:Experimental

Drug Induced Liver Injury-Clinical

• CD-01 Predictors of Drug Toxicity and Therapy

Drug Induced Liver Injury-Basic

• BD-01 Pathogenesis and Mechanisms

• BD-02 Drug Metabolism, and Toxicity

Hepatitis A and E-Clinical

• CE-01 Hepatitis A and E- Clinical and Therapeutic

Hepatitis A and E-Basic

• BE-01 Hepatitis A and Experimental

Liver Fibrogenesis and Non-Parenchymal Cell Biology-Clinical

• BF-01 Imaging and Noninvasive Markers of Liver Fibrosis 

• BF-02 Clinical and Translational Fibrosis Research and Therapy

Liver Fibrogenesis and Non-Parenchymal Cell Biology-Basic

• BF-01 Basic Fibrosis Research and Stellate Cell Biology

Genetic and Metabolic Disease-Clinical

• CG-01 Hemochromatosis, Wilson Disease, ∝-1 Antitrypsin Deficiency-Clinical

• CG-02 Other genetic and metabolic disorders-Clinical

Genetic and Metabolic Disease-Basic

• BG-01 Hemochromatosis, Wilson Disease, ∝-1 Antitrypsin Deficiency-Experimental

• BG-02 Other genetic and metabolic disorders-Experimental

Inflammation and Immunology-Basic 

• BI-01 Animal Models

• BI-02 Innate Immunity

• BI-03 Adaptive Immunity

• BI-04 Mechanisms of Injury and others

Liver Cancer-Clinical 

• CLC-01 Diagnostics and Liver Imaging of hepatocellular carcinoma

• CLC-02 Prognosis : Hepatocellular Carcinoma

• CLC-03 Liver transplantation, Surgery and Loco-Regional Therapy for    Hepatocellular Carcinoma

• CLC-04 Targetted and systemic therapies for Hepatocellular Carcinoma

Liver Cancer -Basic 

• BLC-01 Experimental Hepatocarcinogenesis

Liver Transplantation and Liver Surgery-Clinical

• CLTS-01 Donor and Allocation Issues; Living Donor and Split Liver Transplantation, 

• CLTS-02 Immunosuppression, Outcomes, Complications of liver transplantation

• CLTS-03 Viral Hepatitis and liver transplantation 

• CLTS-04 Hepatobiliary Surgery

Liver Transplantation and Liver Surgery-Basic

• BLTS-01 Cellular Immunobiology, Preservation and Cell Transplantation, Experimental

Molecular and Cellular  Biology and Stem Cell Therapy -Basic

• BM-01 Cell Structure; Function; Signal Transduction, Nuclear Receptors

• BM-02 Gene Expression and Gene Therapy

• BM-03 Stem Cell Biology- Basic Sciences

• BM-04 Stem cell therapy: Clinical

Portal Hypertension and Other Complications of Cirrhosis-Clinical

• CP-01 Ascites, Renal Dysfunction and Hepatorenal Syndrome

• CP-02 Varices and Bleeding

• CP-03 Encephalopathy and Infections and Other Complications

• C-P04 Acute on Chronic Liver Failure

Portal Hypertension and Other Complications of Cirrhosis including ACLF-Basic

• BP-01 Experimental

Pediatric Hepatology-Clinical

• CPD-01 Biliary Atresia and Cholestasis

• CPD-02 Viral and Autoimmune Hepatitis

• CPD-03 Metabolic and Genetic Diseases

• CPD-04 Pediatric Liver Transplantation

Pediatric Hepatology-Basic

• BPD-01 Pediatric Liver Disease - Basic Science

Public Health Services Research

• CPH-01 Health Care Delivery/Access/Quality

• CPH-02 Health Economics and Cost-Effectiveness and Economics of Care

• CPH-03 Other public health issues


• CM-01 Miscellaneous issues-Clinical


• BM-01: Miscellaneous issues-Experimental

NAFLD / NASH - Clinical

• CNA - 01

NAFLD / NASH - Basic

• BNA - 01



Abstract Title

There is a limit of 300 characters, including spaces, for the title of an abstract.


Please list all authors with their affiliations (institution, city and country).


Credit for authorship requires substantial contributions to the conception and design; or the acquisition, analysis, or interpretation of the data, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved.

Abstract Body

There is a limit of 3000 characters, including spaces, for the body of abstract submissions. Abstract titles, author names, author institutions, and information in tables and images do not count toward the 3000 character limit. Abstract text for original article should include 1) background/aims, 2) methods, 3) results and 4) conclusions. For case report, it should include introduction and case description. Do not include references and key words in the abstract.

Tables and Figures

A maximum of 2 images can be included per abstract. The maximum file size of each graph/image is 2M. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. Graphs and images may be uploaded in JPG, PNG and GIF format only. When including a table it is recommended to save the table as an image and then upload it in to the abstract.


Use the abbreviation in parentheses after the full word the first time it appears. 

To avoid character corruption, please use only Times New Roman font.

Font size should be 10.

Editing A Submitted Abstract

Authors may edit submitted abstracts until the submissions deadline. Abstract submitters should log into their registration account to make any edits.

Sponsors Exhibitors
General Info

Summit - Alpcord Network

1201, 12th Floor, New Delhi House, 27,

Barakhamba Road, New Delhi - 110001


Contact Person:

Ms. Ruchi Anthwal

Mob.: +91-9971100625

Tel.: +91-11-49104117

Exhibition Consensus
Exhibition Floor plans
Organising Agency

Summit - Alpcord Network

1201, 12th Floor, New Delhi House, 27,

Barakhamba Road, New Delhi - 110001


Contact Person:

Ms. Ruchi Anthwal

Mob.: +91-9971100625

Tel.: +91-11-49104117

Official Event Webpage
Event map
Revelant Events